Qv Investors Inc. Haemonetics Corp Transaction History
Qv Investors Inc.
- $990 Million
- Q1 2025
A detailed history of Qv Investors Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Qv Investors Inc. holds 11,240 shares of HAE stock, worth $708,344. This represents 0.07% of its overall portfolio holdings.
Number of Shares
11,240Holding current value
$708,344% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
344Shares Held
52.4MCall Options Held
600KPut Options Held
474K-
Black Rock Inc. New York, NY5.96MShares$376 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.18MShares$326 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.42MShares$279 Million0.29% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.24MShares$267 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.55MShares$161 Million0.12% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.23B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...